GoodRx Holdings, Inc. - Class A (GDRX) earnings
GDRX earnings moved a median of +0.39% by the close. Quarterly and annual GDRX reports and results, each read against the price at its own news timestamp. Back to the GDRX overview →
32 measured GDRX earnings events.
Where these GDRX earnings landedvs 32 measured GDRX earnings reactions
| Middle 50% of GDRX earnings reactions | -1.02% to +3.42% |
|---|---|
| Median reaction (to close) | +0.39% |
| Measured reactions | 32 |
Point-in-time · zero look-ahead
Half of the 32 GDRX earnings events with a measured close landed between -1.02% and +3.42%; 53% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q GoodRx Holdings, Inc. For: Jun 30 | SEC filing · Form 10-Q | -1.75% | +8.77% | |
| GoodRx Reports Second Quarter 2026 Results | Press release | -1.75% | +8.77% | |
| GoodRx Announces Date for Second Quarter 2026 Earnings Release and Conference Call | Press release | +0.34% | -0.34% | |
| Form 10-Q GoodRx Holdings, Inc. For: Mar 31 | SEC filing · Form 10-Q | +5.58% | +13.15% | |
| GoodRx Reports First Quarter 2026 Results | Press release | +5.58% | +13.15% | |
| GoodRx Announces Date for First Quarter 2026 Earnings Release and Conference Call | Press release | +0.88% | +4.41% | |
| Form 10-K GoodRx Holdings, Inc. For: Dec 31 | SEC filing · Form 10-K | -0.99% | -0.50% | |
| GoodRx Announces Date for Fourth Quarter and Full Year 2025 Earnings Release and Conference Call | Press release | -0.64% | +3.00% | |
| Form 10-Q GoodRx Holdings, Inc. For: Sep 30 | SEC filing · Form 10-Q | -0.15% | -0.89% | |
| GoodRx Reports Third Quarter 2025 Results | Press release | -0.15% | -0.89% | |
| GoodRx Announces Date for Third Quarter 2025 Earnings Release and Conference Call | Press release | +0.23% | +4.27% | |
| Form 10-Q GoodRx Holdings, Inc. For: Jun 30 | SEC filing · Form 10-Q | -8.27% | -13.25% | |
| GoodRx Reports Second Quarter 2025 Results | Press release | -8.27% | -13.25% | |
| GoodRx Announces Date for Second Quarter 2025 Earnings Release and Conference Call | Press release | -1.02% | +0.41% | |
| Form 10-Q GoodRx Holdings, Inc. For: Mar 31 | SEC filing · Form 10-Q | -0.74% | +5.21% | |
| GoodRx Reports First Quarter 2025 Results | Press release | -0.74% | +5.21% | |
| GoodRx Announces Date for First Quarter 2025 Earnings Release and Conference Call | Press release | -0.66% | -5.26% | |
| Form 10-K GoodRx Holdings, Inc. For: Dec 31 | SEC filing · Form 10-K | -3.28% | +2.05% | |
| GoodRx Announces Date for Fourth Quarter and Full Year 2024 Earnings Release and Conference Call | Press release | +1.87% | -0.83% | |
| Form 10-Q GoodRx Holdings, Inc. For: Sep 30 | SEC filing · Form 10-Q | +0.20% | +2.75% | |
| GoodRx Reports Third Quarter 2024 Results | Press release | -19.30% | -16.14% | |
| GoodRx Announces Date for Third Quarter 2024 Earnings Release and Conference Call | Press release | -0.87% | -0.43% | |
| Form 10-Q GoodRx Holdings, Inc. For: Jun 30 | SEC filing · Form 10-Q | -0.07% | +1.37% | |
| GoodRx Reports Second Quarter 2024 Results | Press release | -7.68% | -2.10% | |
| GoodRx Announces Date for Second Quarter 2024 Earnings Release and Conference Call | Press release | -0.38% | +0.38% | |
| Form 10-Q GoodRx Holdings, Inc. For: Mar 31 | SEC filing · Form 10-Q | +0.43% | +0.51% | |
| GoodRx Reports First Quarter 2024 Results | Press release | -1.41% | -2.39% | |
| GoodRx Announces Date for First Quarter 2024 Earnings Release and Conference Call | Press release | +0.47% | -0.29% | |
| Form 10-K GoodRx Holdings, Inc. For: Dec 31 | SEC filing · Form 10-K | — | -1.39% | |
| GoodRx Announces Date for Fourth Quarter and Full Year 2023 Earnings Release and Conference Call | Press release | -1.29% | +2.65% | |
| Form 10-Q GoodRx Holdings, Inc. For: Sep 30 | SEC filing · Form 10-Q | -0.12% | +3.14% | |
| GoodRx Reports Third Quarter 2023 Results | Press release | -10.52% | -16.70% |
Keep exploring
More GDRX: analyst actions → · SEC filings → · GDRX overview →